FDA to authorize 3rd COVID-19 vaccine dose for immunocompromised people

On Thursday (Aug. 12), the U.S. Food and Drug Administration (FDA) is planning to authorize a third vaccine dose for people with weakened immune systems, according to recent news reports.

The FDA will update the emergency use authorizations for the two mRNA vaccines — Pfizer/BioNTech and Moderna —to include a third dose for immunocompromised patients. That would be the first authorization of a third dose in the U.S., according to NBC News, which first reported the news.
Around 2.7% of the adult population in the U.S. are immunocompromised, according to meeting slides from an advisory committee to the Centers for Disease Control and Prevention (CDC) that met in July to discuss the supplemental doses.

Read more rest from:-
https://www.livescience.com/fda-will-authorize-third-covid-19-dose-immunocompromised-people.html